Anti-inflammatory and anti-osteoarthritis effect of Mollugo pentaphylla extract
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 57 (1) , 73-80
Abstract
Context: Mollugo pentaphylla L. (Molluginaceae) extract (MPE) has been reported to have anti-inflammatory effect on MSU-induced gouty arthritis in a mouse model. Objective: This study examined the anti-inflammatory activities of an MPE in vitro and anti-osteoarthritis effects on monosodium iodoacetate (MIA)-induced osteoarthritis (OA) in vivo. Materials and methods: The dried whole plants of M. pentaphylla were extracted with 70% ethanol under reflux. The anti-inflammatory effect of MPE was evaluated in vitro in lipopolysaccharide (LPS)-treated RAW264.7 cells. The anti-osteoarthritic effect of MPE was investigated in a Sprague–Dawley rat model of MIA-induced OA. Each seven male rats were orally administered MPE (75, 150 or 300 mg/kg) or the positive control drug indomethacin (1 mg/kg) 3 days before MIA injection and once daily for 11 days thereafter. After the treatment with MPE, no evidence of systemic adverse effects was observed in any study group. Results: MPE exhibited anti-inflammatory activity via inhibition of the production of NO (57.8%), PGE2 (97.1%) and IL-6 (93.2%) in LPS-treated RAW264.7 cells at 200 μg/mL. In addition, MPE suppressed IL-1β (60.9%), TNF-α (37.9%) and IL- 6 (40.9%) production and suppressed the synthesis of MMP-2, MMP-9 and COX-2 in the MIA-induced OA rat model. Conclusions: These results demonstrate that MPE exerts potent anti-inflammatory activities and protects cartilage in an OA rat model. This might be a potential candidate for therapeutic OA treatment.Keywords
Funding Information
- Korea Institute of Oriental Medicine (0)
This publication has 40 references indexed in Scilit:
- Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretationsTherapeutic Advances in Musculoskeletal Disease, 2013
- Current interventions in the management of knee osteoarthritisJournal of Pharmacy and Bioallied Sciences, 2013
- Effect of a Herbal-Leucine mix on the IL-1β-induced cartilage degradation and inflammatory gene expression in human chondrocytesBMC Complementary and Alternative Medicine, 2011
- Current concepts in the pathogenesis of osteoarthritisOsteoarthritis and Cartilage, 2008
- MAPKs and their relevance to arthritis and inflammationRheumatology, 2007
- Vasoactive intestinal peptide (VIP) is a modulator of joint pain in a rat model of osteoarthritisPain, 2006
- Treatment of OsteoarthritisSouthern Medical Journal, 2005
- Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF- BCarcinogenesis, 2003
- Glucosamine inhibits IL-1β-induced NFκB activation in human osteoarthritic chondrocytesOsteoarthritis and Cartilage, 2003
- Can altered production of interleukin-1β, interleukin-6, transforming growth factor-β and prostaglandin E2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patientsOsteoarthritis and Cartilage, 2002